Table of contents : Front Matter....Pages i-xi Internal Standards for Quantitative LC-MS Bioanalysis....Pages 1-32 Method Development, Validation, and Sample Analysis for Regulated Quantitative Bioanalysis Using LC-MS/MS....Pages 33-66 Impact of Sampling Paper/Cards on Bioanalytical Quantitation via Dried Blood Spots by Liquid Chromatography-Mass Spectrometry....Pages 67-80 Highly Sensitive Pharmaceutical and Clinical Analysis Using Selective Solid-Phase Extraction Coupled to Microflow Liquid Chromatography and Isotope-Dilution Mass Spectrometry....Pages 81-107 Pitfalls of LC-MS/MS in the Clinical Laboratory....Pages 109-126 Therapeutic Drug Monitoring to Support Clinical Pharmacogenomics....Pages 127-141 Liquid Chromatography-Mass Spectrometry for the Determination of Antidepressants and Some of their Major Metabolites in Human Biological Matrices....Pages 143-175 The Analysis of Antipsychotic Drugs in Human Biosamples by LC-MS....Pages 177-195 Therapeutic Drug Monitoring of Targeted Anticancer Therapy. Tyrosine Kinase Inhibitors and Selective Estrogen Receptor Modulators: A Clinical Pharmacology Laboratory Perspective....Pages 197-250 Applications of Mass Spectrometry in Analyses of Steroid Hormones....Pages 251-286 Liquid Chromatography-Mass Spectrometric Analysis of Tropane Alkaloids in Mammalian Samples: Techniques and Applications....Pages 287-347 Analysis of Illicit Drugs in Human Biological Samples by LC-MS n ....Pages 349-398 Use of Matrix Assisted Laser Desorption/Ionization Imaging Mass Spectrometry (MALDI-IMS) in the Development of Novel Small Molecule Drugs....Pages 399-422 A Planar Integrated Micro-mass Spectrometer....Pages 423-465 Back Matter....Pages 467-469